Bristol-Myers Squibb Company
NYSE: BMY
$49.41
+$0.39 (+0.8%)
Closing Price on September 20, 2024
BMY Articles
We may have just witnessed an oversold bounce in the stock market, or we may be in for more days of recovery. The markets are flirting with six weeks of negative performance and one day is not...
Published:
Last Updated:
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday morning. Aixtron SE (NASDAQ: AIXG) Cut to Sell at Canaccord Genuity....
Published:
Last Updated:
The fight against melanoma just got a new weapon after a drug called Yervoy, or ipilimumab, was given FDA approval for late-stage metastatic melanoma. The approval is a win for Bristol-Myers...
Published:
Last Updated:
Earnings season may still be in force, but we are looking for the coming week’s top coming events that could have a large impact on shares on Monday and throughout the week. What has been known...
Published:
Last Updated:
Dell’s (NASDAQ: DELL) margins rushed past expectations and shares moved higher (Reuters) Bernanke said a strong US recovery is essential to global economic health (Reuters) Lawmakers attacked...
Published:
Last Updated:
Bristol-Myers Squibb (NYSE: BMY) will cut nearly 1,000 workers. That is on top of large rounds of firings in 2007 and 2008. The company gave an odd reason for the action.”The ultimate goal of the...
Published:
Reuters: Petrobras raised $70 billion in the largest stock offer in history. Reuters: There will likely be no tax cut before the election, according to Democrats Reuters: Obama asked the...
Published:
Reuters: Japan’s plan to intervene in yen trading has not moved the currency lower. Reuters: Oil dropped as investor moved away from risk Reuters: Hewlett-Packard (NYSE: HPQ) sued to...
Published:
These are some of this Friday’s top analyst calls with upgrades, downgrades, and initiations seen in Wall Street research notes: American Eagle Outfitters, Inc. (NYSE: AEO) Raised to Buy at...
Published:
Last Updated:
Today’s edition of the BioHealth Business Daily is going to be very cancer-dominated due to the American Society of Clinical Oncology (ASCO) 2010 meeting that started this last weekend. There are...
Published:
Last Updated:
We have several big movers on news this morning, and none appear to be based upon earnings. Stocks on the move are ArQule Inc. (NASDAQ: ARQL), BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX),...
Published:
Last Updated:
These are some of the major research calls we have seen from analysts in their upgrades, downgrades, and initiations so far this Monday: Amazon.com, Inc. (NASDAQ: AMZN) Raised to Conviction Buy List...
Published:
Last Updated:
The pharmaceutical industry has found a growing source of sales–the prescription of medicines, primarily used by adults in the past, to children. A portion of the sharp increase in drugs used by...
Published:
A look at the “hardest working” major brands for 2009 shows that a number of them belong to companies which have done poorly and, in at least one case, may file Chapter 11. This is due to the...
Published:
Reuters: The Senate overcame opposition to allow jobless benefits to be extended. Reuters: China will hope to keep the value of the yuan steady. Reuters: JC Penney (JCP) will focus on...
Published: